{"id":"https://openalex.org/W2345476545","doi":"https://doi.org/10.1371/journal.pone.0154778","title":"A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis","display_name":"A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis","publication_year":2016,"publication_date":"2016-05-09","ids":{"openalex":"https://openalex.org/W2345476545","doi":"https://doi.org/10.1371/journal.pone.0154778","mag":"2345476545","pmid":"https://pubmed.ncbi.nlm.nih.gov/27159505","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4861335"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0154778","doi":"https://doi.org/10.1371/journal.pone.0154778","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0154778","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0154778&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0154778&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060315708","display_name":"Marcus Barreto Conde","orcid":"https://orcid.org/0000-0002-7249-4455","observed_orcids":["https://orcid.org/0000-0002-7249-4455"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Marcus B. Conde","raw_affiliation_strings":["Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091633123","display_name":"Fernanda Carvalho de Queiroz Mello","orcid":"https://orcid.org/0000-0003-3250-6738","observed_orcids":["https://orcid.org/0000-0003-3250-6738"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Fernanda C. Q. Mello","raw_affiliation_strings":["Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033614039","display_name":"Rafael Silva Duarte","orcid":"https://orcid.org/0000-0001-6457-1900","observed_orcids":["https://orcid.org/0000-0001-6457-1900"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Rafael Silva Duarte","raw_affiliation_strings":["Instituto de Microbiologia Paulo de G\u00f3es, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Microbiologia Paulo de G\u00f3es, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008062120","display_name":"Solange Cesar Cavalcante","orcid":"https://orcid.org/0000-0002-4154-7016","observed_orcids":["https://orcid.org/0000-0002-4154-7016"]},"institutions":[{"id":"https://openalex.org/I4405286924","display_name":"Instituto Nacional de Infectologia Evandro Chagas","ror":"https://ror.org/03jw34240","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4405286924","https://openalex.org/I52325"]},{"id":"https://openalex.org/I52325","display_name":"Funda\u00e7\u00e3o Oswaldo Cruz","ror":"https://ror.org/04jhswv08","country_code":"BR","type":"facility","lineage":["https://openalex.org/I52325"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Solange C. Cavalcante","raw_affiliation_strings":["Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil","Municipal Health Secretariat, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4405286924","https://openalex.org/I52325"]},{"raw_affiliation_string":"Municipal Health Secretariat, Rio de Janeiro, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020812138","display_name":"Val\u00e9ria C. Rolla","orcid":"https://orcid.org/0000-0002-0841-1408","observed_orcids":["https://orcid.org/0000-0002-0841-1408"]},"institutions":[{"id":"https://openalex.org/I4405286924","display_name":"Instituto Nacional de Infectologia Evandro Chagas","ror":"https://ror.org/03jw34240","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4405286924","https://openalex.org/I52325"]},{"id":"https://openalex.org/I52325","display_name":"Funda\u00e7\u00e3o Oswaldo Cruz","ror":"https://ror.org/04jhswv08","country_code":"BR","type":"facility","lineage":["https://openalex.org/I52325"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Valeria Rolla","raw_affiliation_strings":["Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4405286924","https://openalex.org/I52325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022981171","display_name":"Margareth Pretti Dalcolmo","orcid":"https://orcid.org/0000-0002-6820-1082","observed_orcids":["https://orcid.org/0000-0002-6820-1082"]},"institutions":[{"id":"https://openalex.org/I4210121739","display_name":"Minist\u00e9rio da Sa\u00fade","ror":"https://ror.org/02y7p0749","country_code":"BR","type":"government","lineage":["https://openalex.org/I4210121739"]},{"id":"https://openalex.org/I52325","display_name":"Funda\u00e7\u00e3o Oswaldo Cruz","ror":"https://ror.org/04jhswv08","country_code":"BR","type":"facility","lineage":["https://openalex.org/I52325"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Margareth Dalcolmo","raw_affiliation_strings":["Centro de Refer\u00eancia H\u00e9lio Fraga, Minist\u00e9rio da Sa\u00fade, Fiocruz Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Refer\u00eancia H\u00e9lio Fraga, Minist\u00e9rio da Sa\u00fade, Fiocruz Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210121739","https://openalex.org/I52325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009033469","display_name":"Carla Loredo","orcid":"https://orcid.org/0000-0002-1480-1701","observed_orcids":["https://orcid.org/0000-0002-1480-1701"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Carla Loredo","raw_affiliation_strings":["Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067606604","display_name":"Betina Durovni","orcid":"https://orcid.org/0000-0002-5555-8015","observed_orcids":["https://orcid.org/0000-0002-5555-8015"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Betina Durovni","raw_affiliation_strings":["Municipal Health Secretariat, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Municipal Health Secretariat, Rio de Janeiro, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031840002","display_name":"Derek T. Armstrong","orcid":"https://orcid.org/0000-0001-6223-4839","observed_orcids":["https://orcid.org/0000-0001-6223-4839"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Derek T. Armstrong","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112470741","display_name":"Anne Efron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Efron","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059911706","display_name":"Grace Link Barnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grace L. Barnes","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082007029","display_name":"Mark A. Marzinke","orcid":"https://orcid.org/0000-0003-1670-8786","observed_orcids":["https://orcid.org/0000-0003-1670-8786"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Marzinke","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003508947","display_name":"Radojka M. Savi\u0107","orcid":"https://orcid.org/0000-0003-3143-5579","observed_orcids":["https://orcid.org/0000-0003-3143-5579","https://orcid.org/0009-0001-3093-9081"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Radojka M. Savic","raw_affiliation_strings":["University of California San Francisco, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, California, United States of America","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007514947","display_name":"Kelly E. Dooley","orcid":"https://orcid.org/0000-0001-9013-5256","observed_orcids":["https://orcid.org/0000-0001-9013-5256"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly E. Dooley","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108694624","display_name":"Silvia E. Cohn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Silvia Cohn","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082657568","display_name":"Lawrence H. Moulton","orcid":"https://orcid.org/0000-0001-7041-7387","observed_orcids":["https://orcid.org/0000-0001-7041-7387"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence H. Moulton","raw_affiliation_strings":["Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071106707","display_name":"Richard E. Chaisson","orcid":"https://orcid.org/0000-0003-4710-925X","observed_orcids":["https://orcid.org/0000-0003-4710-925X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E. Chaisson","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113843299","display_name":"Susan E. Dorman","orcid":"https://orcid.org/0000-0001-6882-9470","observed_orcids":["https://orcid.org/0000-0001-6882-9470"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Susan E. Dorman","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5113843299"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":4.4446,"has_fulltext":true,"cited_by_count":36,"citation_normalized_percentile":{"value":0.94691837,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"5","first_page":"e0154778","last_page":"e0154778"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulmonary-tuberculosis","display_name":"pulmonary tuberculosis","score":0.9589999914169312},{"id":"https://openalex.org/keywords/rifapentine","display_name":"rifapentine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/moxifloxacin","display_name":"moxifloxacin","score":1.0},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.8759999871253967},{"id":"https://openalex.org/keywords/pyrazinamide","display_name":"pyrazinamide","score":1.0},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.800000011920929},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.996999979019165},{"id":"https://openalex.org/keywords/sputum-culture-conversion","display_name":"sputum conversion","score":0.7300000190734863},{"id":"https://openalex.org/keywords/bactericidal-activity","display_name":"bactericidal activity","score":0.9639999866485596},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7089999914169312},{"id":"https://openalex.org/keywords/smear-positive-pulmonary-tuberculosis","display_name":"smear-positive tuberculosis","score":0.7099999785423279},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5299999713897705},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2776991065","wikidata":"https://www.wikidata.org/wiki/Q3935297","display_name":"Rifapentine","level":5,"score":0.946705162525177},{"id":"https://openalex.org/C2778836808","wikidata":"https://www.wikidata.org/wiki/Q424940","display_name":"Moxifloxacin","level":3,"score":0.9438278079032898},{"id":"https://openalex.org/C2780459521","wikidata":"https://www.wikidata.org/wiki/Q417571","display_name":"Pyrazinamide","level":4,"score":0.8716466426849365},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8175621032714844},{"id":"https://openalex.org/C2776228421","wikidata":"https://www.wikidata.org/wiki/Q412318","display_name":"Ethambutol","level":4,"score":0.7045978307723999},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.631144642829895},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.6054224967956543},{"id":"https://openalex.org/C2776301714","wikidata":"https://www.wikidata.org/wiki/Q259346","display_name":"Sputum","level":3,"score":0.5867869257926941},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5551156401634216},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.52488774061203},{"id":"https://openalex.org/C2776306059","wikidata":"https://www.wikidata.org/wiki/Q388565","display_name":"Rifamycin","level":3,"score":0.4888407588005066},{"id":"https://openalex.org/C2779912665","wikidata":"https://www.wikidata.org/wiki/Q7581635","display_name":"Sputum culture","level":4,"score":0.4681952893733978},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.45899254083633423},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4197736084461212},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.405200719833374},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3402462303638458},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3308205008506775},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.272832453250885},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.25311893224716187},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.21480706334114075},{"id":"https://openalex.org/C2779806340","wikidata":"https://www.wikidata.org/wiki/Q4254929","display_name":"Latent tuberculosis","level":4,"score":0.20101770758628845},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0843418538570404},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0754830539226532},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.05799701809883118}],"mesh":[{"descriptor_ui":"D000077266","descriptor_name":"Moxifloxacin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011718","descriptor_name":"Pyrazinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011718","descriptor_name":"Pyrazinamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":11,"locations":[{"id":"doi:10.1371/journal.pone.0154778","doi":"https://doi.org/10.1371/journal.pone.0154778","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0154778","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0154778&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4861335","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4861335","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:27159505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27159505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:americanae.aecid.es:2317306","doi":null,"is_oa":true,"landing_page_url":"https://www.arca.fiocruz.br/handle/icict/31845","pdf_url":null,"source":{"id":"https://openalex.org/S4306400786","display_name":"Americanae (AECID Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"reponame:Reposit\u00f3rio Institucional da FIOCRUZ (ARCA)","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:oai:RePEc:plo:pone00:0154778","doi":null,"is_oa":false,"landing_page_url":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154778","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:arca.fiocruz.br:icict/31845","doi":null,"is_oa":true,"landing_page_url":"https://arca.fiocruz.br/handle/icict/31845","pdf_url":null,"source":{"id":"https://openalex.org/S7407055450","display_name":"Arca - Reposit\u00f3rio Institucional da Fiocruz","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:doaj.org/article:9a19095927fe4516a1a339062f93ff6f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9a19095927fe4516a1a339062f93ff6f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 11, Iss 5, p e0154778 (2016)","raw_type":"article"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt8p79n9sd","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/8p79n9sd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/3368170","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/A_Phase_2_Randomized_Trial_of_a_Rifapentine_plus_Moxifloxacin-Based_Regimen_for_Treatment_of_Pulmonary_Tuberculosis/3368170","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:www.arca.fiocruz.br:icict/31845","doi":null,"is_oa":true,"landing_page_url":"https://www.arca.fiocruz.br/handle/icict/31845","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"reponame:Reposit\u00f3rio Institucional da FIOCRUZ (ARCA)","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:qt8p79n9sd","doi":null,"is_oa":true,"landing_page_url":"http://www.escholarship.org/uc/item/8p79n9sd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Savic, Radojka; Conde, MB; Mello, FCQ; Duarte, RS; Cavalcante, SC; Rolla, V; \u00c2\u00a0et al.(2016). A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/8p79n9sd","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0154778","doi":"https://doi.org/10.1371/journal.pone.0154778","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0154778","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0154778&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1357855767","display_name":"Innovative Approaches to Tuberculosis Control","funder_award_id":"U19AI045432","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G295005675","display_name":"PK/PD Issues in the Use of New Therapies for the Treatment of Tuberculosis","funder_award_id":"K23AI080842","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6547924999","display_name":"Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics","funder_award_id":"K24AI104830","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7282604809","display_name":"Clinical Research in Tuberculosis","funder_award_id":"K24AI001637","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7465148595","display_name":"Rapid Detection of Mycobacterium tuberculosis","funder_award_id":"K23AI051528","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000866595","display_name":"Clinical Pharmacology Training Program","funder_award_id":"T32GM066691","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000874350","display_name":"The Johns Hopkins Center for AIDS Research (JHU CFAR)","funder_award_id":"P30AI094189","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"},{"id":"https://openalex.org/F4320337422","display_name":"National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention","ror":"https://ror.org/01wjn2x92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2345476545.pdf","grobid_xml":"https://content.openalex.org/works/W2345476545.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W104155408","https://openalex.org/W113437334","https://openalex.org/W233147817","https://openalex.org/W1867048120","https://openalex.org/W1965877207","https://openalex.org/W1973110906","https://openalex.org/W1979650517","https://openalex.org/W2008916602","https://openalex.org/W2011386209","https://openalex.org/W2033228816","https://openalex.org/W2047509792","https://openalex.org/W2047701762","https://openalex.org/W2059786651","https://openalex.org/W2069392205","https://openalex.org/W2072475014","https://openalex.org/W2076991882","https://openalex.org/W2089663335","https://openalex.org/W2101401313","https://openalex.org/W2105096884","https://openalex.org/W2106892252","https://openalex.org/W2111276287","https://openalex.org/W2120390077","https://openalex.org/W2120761149","https://openalex.org/W2122919033","https://openalex.org/W2125648033","https://openalex.org/W2134655561","https://openalex.org/W2139696962","https://openalex.org/W2140080435","https://openalex.org/W2143048500","https://openalex.org/W2152562731","https://openalex.org/W2155898568","https://openalex.org/W2159717558","https://openalex.org/W2169203610","https://openalex.org/W2405710268","https://openalex.org/W2418210342","https://openalex.org/W2422352973","https://openalex.org/W2475221066","https://openalex.org/W2612081687"],"related_works":["https://openalex.org/W3159002700","https://openalex.org/W2105096884","https://openalex.org/W2139696962","https://openalex.org/W2111276287","https://openalex.org/W2143048500","https://openalex.org/W7126152460","https://openalex.org/W3000751718","https://openalex.org/W2135989318","https://openalex.org/W2134655561","https://openalex.org/W2047701762"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,22,97,246],"combination":[2,313],"of":[3,19,24,39,43,56,106,109,115,122,125,220,248,280],"rifapentine":[4,72,206,221,239,325],"and":[5,37,47,95,316],"moxifloxacin":[6,77,228,321],"administered":[7,49],"daily":[8,50,88,309],"with":[9,62,93,244,314],"other":[10,255],"anti-tuberculosis":[11],"drugs":[12],"is":[13],"highly":[14],"active":[15],"in":[16,134,138,148,158,161,171,236,261,291,301,312],"mouse":[17],"models":[18],"tuberculosis":[20,58,66,310],"chemotherapy.":[21],"objective":[23],"this":[25],"phase":[26,308],"2":[27],"clinical":[28],"trial":[29],"was":[30,100,180,199,213,230,240,259,326],"to":[31,69,176,217],"determine":[32],"the":[33,52,139,149,162,172,183,187,209,262,266,278,292,302,332],"bactericidal":[34,330],"activity,":[35],"safety,":[36],"tolerability":[38],"a":[40,318],"regimen":[41,319,334],"comprised":[42],"rifapentine,":[44],"moxifloxacin,":[45],"isoniazid,":[46],"pyrazinamide":[48],"during":[51],"first":[53],"8":[54,90,107,123],"weeks":[55,108,124],"pulmonary":[57,65],"treatment.":[59,110],"METHODS:":[60],"Adults":[61],"sputum":[63,101],"smear-positive":[64],"were":[67,118,287],"randomized":[68],"receive":[70],"either":[71],"(approximately":[73,82],"7.5":[74],"mg/kg)":[75,84],"plus":[76,85,322,337],"(investigational":[78],"arm),":[79],"or":[80,283],"rifampin":[81],"10":[83],"ethambutol":[86,336],"(control)":[87],"for":[89,182,253],"weeks,":[91],"along":[92],"isoniazid":[94,315],"pyrazinamide.":[96],"primary":[98],"endpoint":[99],"culture":[102,178,192],"status":[103],"at":[104,223,327],"completion":[105,121],"RESULTS:":[111],"121":[112],"participants":[113,137,249],"(56%":[114],"accrual":[116],"target)":[117],"enrolled.":[119],"At":[120],"treatment,":[126],"negative":[127,152],"cultures":[128,153],"using":[129,154,190,202],"L\u00f6wenstein-Jensen":[130],"(LJ)":[131],"medium":[132,156,193],"occurred":[133,157],"47/60":[135],"(78%)":[136],"investigational":[140,163,184,263,293],"arm":[141,164,185,189,264,268,294],"vs.":[142,165,186,265,271,295],"43/51":[143],"(84%,":[144],"p":[145,168,274,298],"=":[146,169,195,275,299],"0.47)":[147],"control":[150,173,188,267,303,333],"arm;":[151],"liquid":[155,191],"37/47":[159],"(79%)":[160],"27/41":[166],"(66%,":[167],"0.23)":[170],"arm.":[174],"Time":[175],"stable":[177],"conversion":[179],"shorter":[181],"(p":[194],"0.03),":[196],"but":[197],"there":[198],"no":[200],"difference":[201],"LJ":[203],"medium.":[204],"Median":[205,227],"area":[207],"under":[208],"concentration-time":[210],"curve":[211],"(AUC0-24)":[212],"313":[214],"mcg*h/mL,":[215,232],"similar":[216,288],"recent":[218],"studies":[219],"dosed":[222],"450-600":[224],"mg":[225],"daily.":[226],"AUC0-24":[229],"28.0":[231],"much":[233],"lower":[234],"than":[235,256],"trials":[237],"where":[238],"given":[241],"only":[242],"intermittently":[243],"moxifloxacin.":[245],"proportion":[247],"discontinuing":[250],"assigned":[251],"treatment":[252,311],"reasons":[254],"microbiological":[257],"ineligibility":[258],"higher":[260,284],"(11/62":[269],"[18%]":[270],"3/59":[272],"[5%],":[273],"0.04)":[276],"although":[277],"proportions":[279],"grade":[281],"3":[282],"adverse":[285],"events":[286],"(5/62":[289],"[8%]":[290],"6/59":[296],"[10%,":[297],"0.76]":[300],"arm).":[304],"CONCLUSION:":[305],"For":[306],"intensive":[307],"pyrazinamide,":[317],"containing":[320,335],"low":[323],"dose":[324,339],"least":[328],"as":[329,331],"standard":[338],"rifampin.":[340],"TRIAL":[341],"REGISTRATION:":[342],"www.ClinicalTrials.gov":[343],"NCT00728507.":[344]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}